and the launch of pemetrexed. Figure 2: Market for drugs to treat non-small-cell lung cancer in US $ million. On the basis of second-line use for NSCLC and first-line use for MPM, we forecast ...

Pemetrexed is an (antifolate) antineoplastic agent, prescribed for mesothelioma (cancer that develops from the protective lining of the internal tissues) and certain types of non-small cell lung ...

Concomitant with pemetrexed may increase risk of pemetrexed ... May potentiate protein-bound drugs (eg, phenytoin, sulfonylureas, sulfonamides). May interfere with 5HIAA urinary assays or Porter ...

Concomitant with pemetrexed may increase risk of pemetrexed ... May potentiate protein-bound drugs (eg, phenytoin, sulfonylureas, sulfonamides). May interfere with 5HIAA urinary assays or Porter ...

Discover all the brand names or Trade names of generic drug called Pemetrexed. This serves as a crucial reference for healthcare professionals, patients, caregivers, and anyone looking to ...

Dr Reddy’s Laboratories (pemetrexed) (confidentiality agreement not signed, not participating) Eli Lilly (pemetrexed) (confidentiality agreement not signed, not participating) Genus Pharmaceuticals ...

Suggested remit: To appraise the clinical and cost effectiveness of pembrolizumab with pemetrexed and platinum-based chemotherapy within its marketing authorisation for untreated unresectable advanced ...